STAG2 and acute myeloid leukemia: Furthermore, we observed a relatively stable STAG2 VAF leading up to AML diagnosis (Supplementary Fig. 4C, p = 0.85), suggesting that the STAG2-mutant clone had already dominated the bone marrow in non-leukemic cells before the AML diagnosis was made.